nodes	percent_of_prediction	percent_of_DWPC	metapath
Papaverine—PDE10A—respiratory system—lung cancer	0.0179	0.163	CbGeAlD
Papaverine—Trimethoprim—TYMS—lung cancer	0.0105	0.47	CrCbGaD
Papaverine—PDE3B—bone marrow—lung cancer	0.00979	0.0892	CbGeAlD
Papaverine—PDE10A—lung—lung cancer	0.00952	0.0868	CbGeAlD
Papaverine—PDE3B—lung—lung cancer	0.00887	0.0808	CbGeAlD
Papaverine—PDE4B—respiratory system—lung cancer	0.00736	0.067	CbGeAlD
Papaverine—PDE3A—cardiac atrium—lung cancer	0.00708	0.0646	CbGeAlD
Papaverine—PDE10A—lymph node—lung cancer	0.00651	0.0593	CbGeAlD
Papaverine—Hepatitis—Pemetrexed—lung cancer	0.0062	0.0177	CcSEcCtD
Papaverine—Hepatitis—Gefitinib—lung cancer	0.00616	0.0176	CcSEcCtD
Papaverine—PDE3B—lymph node—lung cancer	0.00607	0.0553	CbGeAlD
Papaverine—PDE4B—bronchus—lung cancer	0.00605	0.0552	CbGeAlD
Papaverine—PDE4B—trachea—lung cancer	0.00544	0.0495	CbGeAlD
Papaverine—Verapamil—ABCC3—lung cancer	0.00542	0.243	CrCbGaD
Papaverine—PDE3A—lung—lung cancer	0.00542	0.0494	CbGeAlD
Papaverine—PDE4B—cardiac atrium—lung cancer	0.00511	0.0465	CbGeAlD
Papaverine—Malaise—Gefitinib—lung cancer	0.00484	0.0138	CcSEcCtD
Papaverine—Flushing—Teniposide—lung cancer	0.00466	0.0133	CcSEcCtD
Papaverine—PDE4B—bone marrow—lung cancer	0.00431	0.0393	CbGeAlD
Papaverine—Blood pressure increased—Paclitaxel—lung cancer	0.00426	0.0122	CcSEcCtD
Papaverine—Anorexia—Pemetrexed—lung cancer	0.0042	0.012	CcSEcCtD
Papaverine—Decreased appetite—Crizotinib—lung cancer	0.00419	0.012	CcSEcCtD
Papaverine—Anorexia—Gefitinib—lung cancer	0.00417	0.0119	CcSEcCtD
Papaverine—Constipation—Crizotinib—lung cancer	0.00412	0.0118	CcSEcCtD
Papaverine—PDE4B—lung—lung cancer	0.00391	0.0356	CbGeAlD
Papaverine—Decreased appetite—Pemetrexed—lung cancer	0.00383	0.0109	CcSEcCtD
Papaverine—Decreased appetite—Gefitinib—lung cancer	0.0038	0.0109	CcSEcCtD
Papaverine—Constipation—Pemetrexed—lung cancer	0.00377	0.0107	CcSEcCtD
Papaverine—Constipation—Gefitinib—lung cancer	0.00374	0.0107	CcSEcCtD
Papaverine—PDE3A—lymph node—lung cancer	0.00371	0.0338	CbGeAlD
Papaverine—Hepatitis—Erlotinib—lung cancer	0.00368	0.0105	CcSEcCtD
Papaverine—Blood pressure increased—Docetaxel—lung cancer	0.00361	0.0103	CcSEcCtD
Papaverine—Anorexia—Teniposide—lung cancer	0.0034	0.0097	CcSEcCtD
Papaverine—Diarrhoea—Crizotinib—lung cancer	0.0033	0.00941	CcSEcCtD
Papaverine—Decreased appetite—Teniposide—lung cancer	0.0031	0.00885	CcSEcCtD
Papaverine—Ill-defined disorder—Vinblastine—lung cancer	0.00309	0.00883	CcSEcCtD
Papaverine—Rash—Crizotinib—lung cancer	0.00304	0.00867	CcSEcCtD
Papaverine—Dermatitis—Crizotinib—lung cancer	0.00304	0.00866	CcSEcCtD
Papaverine—Diarrhoea—Pemetrexed—lung cancer	0.00301	0.0086	CcSEcCtD
Papaverine—Malaise—Vinblastine—lung cancer	0.00301	0.00858	CcSEcCtD
Papaverine—Ill-defined disorder—Topotecan—lung cancer	0.00301	0.00858	CcSEcCtD
Papaverine—Vertigo—Vinblastine—lung cancer	0.003	0.00855	CcSEcCtD
Papaverine—Diarrhoea—Gefitinib—lung cancer	0.00299	0.00854	CcSEcCtD
Papaverine—Flushing—Vinorelbine—lung cancer	0.00295	0.00843	CcSEcCtD
Papaverine—Feeling abnormal—Teniposide—lung cancer	0.00294	0.00839	CcSEcCtD
Papaverine—Malaise—Topotecan—lung cancer	0.00292	0.00833	CcSEcCtD
Papaverine—Nausea—Crizotinib—lung cancer	0.00286	0.00817	CcSEcCtD
Papaverine—Abdominal discomfort—Cisplatin—lung cancer	0.00286	0.00815	CcSEcCtD
Papaverine—Discomfort—Vinblastine—lung cancer	0.00281	0.008	CcSEcCtD
Papaverine—Rash—Pemetrexed—lung cancer	0.00278	0.00792	CcSEcCtD
Papaverine—Dermatitis—Pemetrexed—lung cancer	0.00277	0.00791	CcSEcCtD
Papaverine—Rash—Gefitinib—lung cancer	0.00276	0.00787	CcSEcCtD
Papaverine—Dermatitis—Gefitinib—lung cancer	0.00276	0.00786	CcSEcCtD
Papaverine—Discomfort—Topotecan—lung cancer	0.00273	0.00777	CcSEcCtD
Papaverine—PDE4B—lymph node—lung cancer	0.00267	0.0243	CbGeAlD
Papaverine—Trimethoprim—ABCB1—lung cancer	0.00265	0.119	CrCbGaD
Papaverine—Verapamil—ABCG2—lung cancer	0.00263	0.118	CrCbGaD
Papaverine—Nausea—Pemetrexed—lung cancer	0.00262	0.00746	CcSEcCtD
Papaverine—Nausea—Gefitinib—lung cancer	0.0026	0.00742	CcSEcCtD
Papaverine—Anorexia—Vinblastine—lung cancer	0.00259	0.0074	CcSEcCtD
Papaverine—Ill-defined disorder—Vinorelbine—lung cancer	0.00257	0.00734	CcSEcCtD
Papaverine—Anorexia—Topotecan—lung cancer	0.00252	0.00719	CcSEcCtD
Papaverine—Malaise—Vinorelbine—lung cancer	0.0025	0.00713	CcSEcCtD
Papaverine—Anorexia—Erlotinib—lung cancer	0.00249	0.00711	CcSEcCtD
Papaverine—Vertigo—Vinorelbine—lung cancer	0.00249	0.0071	CcSEcCtD
Papaverine—Diarrhoea—Teniposide—lung cancer	0.00244	0.00696	CcSEcCtD
Papaverine—Flushing—Irinotecan—lung cancer	0.00244	0.00695	CcSEcCtD
Papaverine—Decreased appetite—Vinblastine—lung cancer	0.00237	0.00675	CcSEcCtD
Papaverine—Discomfort—Vinorelbine—lung cancer	0.00233	0.00665	CcSEcCtD
Papaverine—Constipation—Vinblastine—lung cancer	0.00233	0.00664	CcSEcCtD
Papaverine—Decreased appetite—Topotecan—lung cancer	0.0023	0.00656	CcSEcCtD
Papaverine—Decreased appetite—Erlotinib—lung cancer	0.00227	0.00649	CcSEcCtD
Papaverine—Constipation—Topotecan—lung cancer	0.00226	0.00645	CcSEcCtD
Papaverine—Rash—Teniposide—lung cancer	0.00225	0.00642	CcSEcCtD
Papaverine—Dermatitis—Teniposide—lung cancer	0.00225	0.00641	CcSEcCtD
Papaverine—Feeling abnormal—Vinblastine—lung cancer	0.00224	0.0064	CcSEcCtD
Papaverine—Constipation—Erlotinib—lung cancer	0.00224	0.00638	CcSEcCtD
Papaverine—Headache—Teniposide—lung cancer	0.00223	0.00638	CcSEcCtD
Papaverine—Flushing—Cisplatin—lung cancer	0.00221	0.00631	CcSEcCtD
Papaverine—Feeling abnormal—Topotecan—lung cancer	0.00218	0.00622	CcSEcCtD
Papaverine—Anorexia—Vinorelbine—lung cancer	0.00216	0.00615	CcSEcCtD
Papaverine—Ill-defined disorder—Irinotecan—lung cancer	0.00212	0.00605	CcSEcCtD
Papaverine—Nausea—Teniposide—lung cancer	0.00212	0.00605	CcSEcCtD
Papaverine—Ill-defined disorder—Gemcitabine—lung cancer	0.00207	0.00589	CcSEcCtD
Papaverine—Malaise—Irinotecan—lung cancer	0.00206	0.00588	CcSEcCtD
Papaverine—Vertigo—Irinotecan—lung cancer	0.00205	0.00586	CcSEcCtD
Papaverine—Flushing—Etoposide—lung cancer	0.00203	0.00578	CcSEcCtD
Papaverine—Malaise—Gemcitabine—lung cancer	0.00201	0.00573	CcSEcCtD
Papaverine—Flushing—Paclitaxel—lung cancer	0.00199	0.00567	CcSEcCtD
Papaverine—Decreased appetite—Vinorelbine—lung cancer	0.00197	0.00561	CcSEcCtD
Papaverine—Constipation—Vinorelbine—lung cancer	0.00193	0.00552	CcSEcCtD
Papaverine—Ill-defined disorder—Cisplatin—lung cancer	0.00193	0.00549	CcSEcCtD
Papaverine—Discomfort—Irinotecan—lung cancer	0.00192	0.00549	CcSEcCtD
Papaverine—Discomfort—Gemcitabine—lung cancer	0.00187	0.00534	CcSEcCtD
Papaverine—Malaise—Cisplatin—lung cancer	0.00187	0.00534	CcSEcCtD
Papaverine—Feeling abnormal—Vinorelbine—lung cancer	0.00186	0.00532	CcSEcCtD
Papaverine—Diarrhoea—Vinblastine—lung cancer	0.00186	0.00531	CcSEcCtD
Papaverine—Hepatitis—Docetaxel—lung cancer	0.00182	0.00518	CcSEcCtD
Papaverine—Diarrhoea—Topotecan—lung cancer	0.00181	0.00516	CcSEcCtD
Papaverine—Diarrhoea—Erlotinib—lung cancer	0.00179	0.00511	CcSEcCtD
Papaverine—Anorexia—Irinotecan—lung cancer	0.00178	0.00507	CcSEcCtD
Papaverine—Ill-defined disorder—Etoposide—lung cancer	0.00176	0.00503	CcSEcCtD
Papaverine—Discomfort—Cisplatin—lung cancer	0.00175	0.00498	CcSEcCtD
Papaverine—Anorexia—Gemcitabine—lung cancer	0.00173	0.00494	CcSEcCtD
Papaverine—Ill-defined disorder—Paclitaxel—lung cancer	0.00173	0.00493	CcSEcCtD
Papaverine—Malaise—Etoposide—lung cancer	0.00171	0.00489	CcSEcCtD
Papaverine—Vertigo—Etoposide—lung cancer	0.00171	0.00487	CcSEcCtD
Papaverine—Headache—Vinblastine—lung cancer	0.00171	0.00486	CcSEcCtD
Papaverine—Flushing—Docetaxel—lung cancer	0.00168	0.00481	CcSEcCtD
Papaverine—Malaise—Paclitaxel—lung cancer	0.00168	0.0048	CcSEcCtD
Papaverine—Vertigo—Paclitaxel—lung cancer	0.00167	0.00478	CcSEcCtD
Papaverine—Rash—Topotecan—lung cancer	0.00167	0.00476	CcSEcCtD
Papaverine—Dermatitis—Topotecan—lung cancer	0.00167	0.00475	CcSEcCtD
Papaverine—Headache—Topotecan—lung cancer	0.00166	0.00473	CcSEcCtD
Papaverine—Rash—Erlotinib—lung cancer	0.00165	0.00471	CcSEcCtD
Papaverine—Dermatitis—Erlotinib—lung cancer	0.00165	0.0047	CcSEcCtD
Papaverine—Headache—Erlotinib—lung cancer	0.00164	0.00468	CcSEcCtD
Papaverine—Decreased appetite—Irinotecan—lung cancer	0.00162	0.00463	CcSEcCtD
Papaverine—Nausea—Vinblastine—lung cancer	0.00162	0.00461	CcSEcCtD
Papaverine—Anorexia—Cisplatin—lung cancer	0.00161	0.00461	CcSEcCtD
Papaverine—Discomfort—Etoposide—lung cancer	0.0016	0.00456	CcSEcCtD
Papaverine—Constipation—Irinotecan—lung cancer	0.0016	0.00455	CcSEcCtD
Papaverine—Decreased appetite—Gemcitabine—lung cancer	0.00158	0.00451	CcSEcCtD
Papaverine—Nausea—Topotecan—lung cancer	0.00157	0.00448	CcSEcCtD
Papaverine—Discomfort—Paclitaxel—lung cancer	0.00157	0.00447	CcSEcCtD
Papaverine—Abdominal discomfort—Methotrexate—lung cancer	0.00157	0.00447	CcSEcCtD
Papaverine—Constipation—Gemcitabine—lung cancer	0.00155	0.00443	CcSEcCtD
Papaverine—Nausea—Erlotinib—lung cancer	0.00155	0.00443	CcSEcCtD
Papaverine—Diarrhoea—Vinorelbine—lung cancer	0.00155	0.00442	CcSEcCtD
Papaverine—Feeling abnormal—Irinotecan—lung cancer	0.00154	0.00439	CcSEcCtD
Papaverine—Feeling abnormal—Gemcitabine—lung cancer	0.0015	0.00427	CcSEcCtD
Papaverine—Anorexia—Etoposide—lung cancer	0.00148	0.00422	CcSEcCtD
Papaverine—Decreased appetite—Cisplatin—lung cancer	0.00147	0.0042	CcSEcCtD
Papaverine—Anorexia—Paclitaxel—lung cancer	0.00145	0.00414	CcSEcCtD
Papaverine—Rash—Vinorelbine—lung cancer	0.00143	0.00407	CcSEcCtD
Papaverine—Dermatitis—Vinorelbine—lung cancer	0.00142	0.00406	CcSEcCtD
Papaverine—Headache—Vinorelbine—lung cancer	0.00142	0.00404	CcSEcCtD
Papaverine—Feeling abnormal—Cisplatin—lung cancer	0.0014	0.00398	CcSEcCtD
Papaverine—Decreased appetite—Etoposide—lung cancer	0.00135	0.00385	CcSEcCtD
Papaverine—Nausea—Vinorelbine—lung cancer	0.00134	0.00383	CcSEcCtD
Papaverine—Constipation—Etoposide—lung cancer	0.00133	0.00379	CcSEcCtD
Papaverine—Decreased appetite—Paclitaxel—lung cancer	0.00132	0.00377	CcSEcCtD
Papaverine—Hepatitis—Methotrexate—lung cancer	0.00131	0.00373	CcSEcCtD
Papaverine—Constipation—Paclitaxel—lung cancer	0.0013	0.00371	CcSEcCtD
Papaverine—Feeling abnormal—Etoposide—lung cancer	0.00128	0.00365	CcSEcCtD
Papaverine—Diarrhoea—Irinotecan—lung cancer	0.00128	0.00364	CcSEcCtD
Papaverine—Feeling abnormal—Paclitaxel—lung cancer	0.00125	0.00358	CcSEcCtD
Papaverine—Diarrhoea—Gemcitabine—lung cancer	0.00124	0.00355	CcSEcCtD
Papaverine—Anorexia—Docetaxel—lung cancer	0.00123	0.00351	CcSEcCtD
Papaverine—Rash—Irinotecan—lung cancer	0.00118	0.00336	CcSEcCtD
Papaverine—Dermatitis—Irinotecan—lung cancer	0.00118	0.00335	CcSEcCtD
Papaverine—Headache—Irinotecan—lung cancer	0.00117	0.00333	CcSEcCtD
Papaverine—Diarrhoea—Cisplatin—lung cancer	0.00116	0.00331	CcSEcCtD
Papaverine—Rash—Gemcitabine—lung cancer	0.00115	0.00327	CcSEcCtD
Papaverine—Dermatitis—Gemcitabine—lung cancer	0.00114	0.00327	CcSEcCtD
Papaverine—Headache—Gemcitabine—lung cancer	0.00114	0.00325	CcSEcCtD
Papaverine—Hepatitis—Doxorubicin—lung cancer	0.00113	0.00323	CcSEcCtD
Papaverine—Decreased appetite—Docetaxel—lung cancer	0.00112	0.0032	CcSEcCtD
Papaverine—Nausea—Irinotecan—lung cancer	0.00111	0.00316	CcSEcCtD
Papaverine—Constipation—Docetaxel—lung cancer	0.0011	0.00315	CcSEcCtD
Papaverine—Verapamil—ABCB1—lung cancer	0.0011	0.0492	CrCbGaD
Papaverine—Nausea—Gemcitabine—lung cancer	0.00108	0.00308	CcSEcCtD
Papaverine—Rash—Cisplatin—lung cancer	0.00107	0.00305	CcSEcCtD
Papaverine—Dermatitis—Cisplatin—lung cancer	0.00107	0.00304	CcSEcCtD
Papaverine—Feeling abnormal—Docetaxel—lung cancer	0.00106	0.00303	CcSEcCtD
Papaverine—Diarrhoea—Etoposide—lung cancer	0.00106	0.00303	CcSEcCtD
Papaverine—Ill-defined disorder—Methotrexate—lung cancer	0.00106	0.00301	CcSEcCtD
Papaverine—Flushing—Doxorubicin—lung cancer	0.00105	0.003	CcSEcCtD
Papaverine—Diarrhoea—Paclitaxel—lung cancer	0.00104	0.00297	CcSEcCtD
Papaverine—Malaise—Methotrexate—lung cancer	0.00103	0.00293	CcSEcCtD
Papaverine—Vertigo—Methotrexate—lung cancer	0.00102	0.00292	CcSEcCtD
Papaverine—Nausea—Cisplatin—lung cancer	0.00101	0.00287	CcSEcCtD
Papaverine—Rash—Etoposide—lung cancer	0.000978	0.00279	CcSEcCtD
Papaverine—Dermatitis—Etoposide—lung cancer	0.000978	0.00279	CcSEcCtD
Papaverine—Headache—Etoposide—lung cancer	0.000972	0.00277	CcSEcCtD
Papaverine—Rash—Paclitaxel—lung cancer	0.000959	0.00274	CcSEcCtD
Papaverine—Dermatitis—Paclitaxel—lung cancer	0.000958	0.00273	CcSEcCtD
Papaverine—Discomfort—Methotrexate—lung cancer	0.000958	0.00273	CcSEcCtD
Papaverine—Headache—Paclitaxel—lung cancer	0.000953	0.00272	CcSEcCtD
Papaverine—Nausea—Etoposide—lung cancer	0.000922	0.00263	CcSEcCtD
Papaverine—Ill-defined disorder—Doxorubicin—lung cancer	0.000915	0.00261	CcSEcCtD
Papaverine—Nausea—Paclitaxel—lung cancer	0.000904	0.00258	CcSEcCtD
Papaverine—Malaise—Doxorubicin—lung cancer	0.000889	0.00254	CcSEcCtD
Papaverine—Vertigo—Doxorubicin—lung cancer	0.000886	0.00253	CcSEcCtD
Papaverine—Anorexia—Methotrexate—lung cancer	0.000886	0.00253	CcSEcCtD
Papaverine—Diarrhoea—Docetaxel—lung cancer	0.000882	0.00252	CcSEcCtD
Papaverine—Discomfort—Doxorubicin—lung cancer	0.00083	0.00237	CcSEcCtD
Papaverine—Rash—Docetaxel—lung cancer	0.000813	0.00232	CcSEcCtD
Papaverine—Dermatitis—Docetaxel—lung cancer	0.000812	0.00232	CcSEcCtD
Papaverine—Decreased appetite—Methotrexate—lung cancer	0.000808	0.0023	CcSEcCtD
Papaverine—Headache—Docetaxel—lung cancer	0.000808	0.0023	CcSEcCtD
Papaverine—Anorexia—Doxorubicin—lung cancer	0.000767	0.00219	CcSEcCtD
Papaverine—Nausea—Docetaxel—lung cancer	0.000766	0.00219	CcSEcCtD
Papaverine—Feeling abnormal—Methotrexate—lung cancer	0.000766	0.00219	CcSEcCtD
Papaverine—Decreased appetite—Doxorubicin—lung cancer	0.0007	0.002	CcSEcCtD
Papaverine—Constipation—Doxorubicin—lung cancer	0.000688	0.00196	CcSEcCtD
Papaverine—Feeling abnormal—Doxorubicin—lung cancer	0.000663	0.00189	CcSEcCtD
Papaverine—Diarrhoea—Methotrexate—lung cancer	0.000636	0.00181	CcSEcCtD
Papaverine—Rash—Methotrexate—lung cancer	0.000586	0.00167	CcSEcCtD
Papaverine—Dermatitis—Methotrexate—lung cancer	0.000586	0.00167	CcSEcCtD
Papaverine—Headache—Methotrexate—lung cancer	0.000582	0.00166	CcSEcCtD
Papaverine—Nausea—Methotrexate—lung cancer	0.000552	0.00157	CcSEcCtD
Papaverine—Diarrhoea—Doxorubicin—lung cancer	0.000551	0.00157	CcSEcCtD
Papaverine—Rash—Doxorubicin—lung cancer	0.000507	0.00145	CcSEcCtD
Papaverine—Dermatitis—Doxorubicin—lung cancer	0.000507	0.00145	CcSEcCtD
Papaverine—Headache—Doxorubicin—lung cancer	0.000504	0.00144	CcSEcCtD
Papaverine—Nausea—Doxorubicin—lung cancer	0.000478	0.00136	CcSEcCtD
Papaverine—PDE10A—Signaling Pathways—BRAF—lung cancer	0.000175	0.000337	CbGpPWpGaD
Papaverine—PDE3A—Signaling Pathways—STK11—lung cancer	0.000173	0.000335	CbGpPWpGaD
Papaverine—PDE10A—Signaling Pathways—IL6R—lung cancer	0.000172	0.000333	CbGpPWpGaD
Papaverine—PDE10A—Signaling Pathways—CREBBP—lung cancer	0.000172	0.000333	CbGpPWpGaD
Papaverine—PDE3B—Signaling Pathways—AVP—lung cancer	0.000172	0.000333	CbGpPWpGaD
Papaverine—PDE3A—Signaling by GPCR—IL6R—lung cancer	0.000172	0.000332	CbGpPWpGaD
Papaverine—PDE3B—GPCR downstream signaling—PIK3CB—lung cancer	0.000172	0.000332	CbGpPWpGaD
Papaverine—PDE4B—GPCR downstream signaling—PIK3CD—lung cancer	0.000171	0.00033	CbGpPWpGaD
Papaverine—PDE10A—Signaling by GPCR—EGFR—lung cancer	0.000169	0.000327	CbGpPWpGaD
Papaverine—PDE4B—Signaling by GPCR—POMC—lung cancer	0.000168	0.000324	CbGpPWpGaD
Papaverine—PDE3A—Signaling Pathways—FOXO3—lung cancer	0.000167	0.000323	CbGpPWpGaD
Papaverine—PDE3B—Signaling Pathways—IGF1R—lung cancer	0.000166	0.00032	CbGpPWpGaD
Papaverine—PDE3B—Hemostasis—PIK3CA—lung cancer	0.000166	0.00032	CbGpPWpGaD
Papaverine—PDE3B—GPCR downstream signaling—CXCL8—lung cancer	0.000165	0.000319	CbGpPWpGaD
Papaverine—PDE4B—Signaling Pathways—STK11—lung cancer	0.000165	0.000319	CbGpPWpGaD
Papaverine—PDE10A—Signaling Pathways—MAP2K1—lung cancer	0.000164	0.000318	CbGpPWpGaD
Papaverine—PDE3A—Hemostasis—KRAS—lung cancer	0.000164	0.000317	CbGpPWpGaD
Papaverine—PDE3A—Signaling by GPCR—MAP2K1—lung cancer	0.000164	0.000317	CbGpPWpGaD
Papaverine—PDE4B—Signaling by GPCR—IL6R—lung cancer	0.000164	0.000316	CbGpPWpGaD
Papaverine—PDE10A—Signaling Pathways—PIK3CD—lung cancer	0.000163	0.000316	CbGpPWpGaD
Papaverine—PDE3A—Signaling by GPCR—PIK3CD—lung cancer	0.000163	0.000315	CbGpPWpGaD
Papaverine—PDE3B—Signaling Pathways—HES1—lung cancer	0.000163	0.000315	CbGpPWpGaD
Papaverine—PDE10A—GPCR downstream signaling—PIK3CA—lung cancer	0.000162	0.000313	CbGpPWpGaD
Papaverine—PDE3B—Hemostasis—TP53—lung cancer	0.00016	0.00031	CbGpPWpGaD
Papaverine—PDE10A—Signaling by GPCR—KRAS—lung cancer	0.00016	0.000309	CbGpPWpGaD
Papaverine—PDE3B—Signaling by GPCR—RAF1—lung cancer	0.00016	0.000309	CbGpPWpGaD
Papaverine—PDE4B—Signaling Pathways—FOXO3—lung cancer	0.000159	0.000308	CbGpPWpGaD
Papaverine—PDE3B—GPCR downstream signaling—IL2—lung cancer	0.000158	0.000305	CbGpPWpGaD
Papaverine—PDE3A—Signaling Pathways—AVP—lung cancer	0.000157	0.000303	CbGpPWpGaD
Papaverine—PDE3A—GPCR downstream signaling—PIK3CB—lung cancer	0.000156	0.000302	CbGpPWpGaD
Papaverine—PDE4B—Signaling by GPCR—MAP2K1—lung cancer	0.000156	0.000301	CbGpPWpGaD
Papaverine—PDE3B—Signaling by GPCR—PIK3CB—lung cancer	0.000156	0.000301	CbGpPWpGaD
Papaverine—PDE4B—Signaling by GPCR—PIK3CD—lung cancer	0.000155	0.000299	CbGpPWpGaD
Papaverine—PDE3B—Hemostasis—HRAS—lung cancer	0.000153	0.000296	CbGpPWpGaD
Papaverine—PDE3A—Signaling Pathways—IGF1R—lung cancer	0.000151	0.000292	CbGpPWpGaD
Papaverine—PDE3A—Hemostasis—PIK3CA—lung cancer	0.000151	0.000291	CbGpPWpGaD
Papaverine—PDE3A—GPCR downstream signaling—CXCL8—lung cancer	0.00015	0.00029	CbGpPWpGaD
Papaverine—PDE3B—Signaling by GPCR—CXCL8—lung cancer	0.00015	0.000289	CbGpPWpGaD
Papaverine—PDE4B—Signaling Pathways—AVP—lung cancer	0.000149	0.000288	CbGpPWpGaD
Papaverine—PDE3B—Signaling Pathways—ERBB3—lung cancer	0.000149	0.000288	CbGpPWpGaD
Papaverine—PDE4B—GPCR downstream signaling—PIK3CB—lung cancer	0.000149	0.000287	CbGpPWpGaD
Papaverine—PDE3A—Signaling Pathways—HES1—lung cancer	0.000148	0.000287	CbGpPWpGaD
Papaverine—PDE10A—Signaling by GPCR—PIK3CA—lung cancer	0.000147	0.000284	CbGpPWpGaD
Papaverine—PDE10A—Signaling Pathways—MDM2—lung cancer	0.000146	0.000283	CbGpPWpGaD
Papaverine—PDE3A—Hemostasis—TP53—lung cancer	0.000146	0.000282	CbGpPWpGaD
Papaverine—PDE10A—Signaling Pathways—RAF1—lung cancer	0.000146	0.000282	CbGpPWpGaD
Papaverine—PDE3A—Signaling by GPCR—RAF1—lung cancer	0.000145	0.000281	CbGpPWpGaD
Papaverine—PDE10A—Signaling Pathways—ERBB2—lung cancer	0.000144	0.000279	CbGpPWpGaD
Papaverine—PDE3A—GPCR downstream signaling—IL2—lung cancer	0.000144	0.000277	CbGpPWpGaD
Papaverine—PDE4B—Signaling Pathways—IGF1R—lung cancer	0.000144	0.000277	CbGpPWpGaD
Papaverine—PDE3B—Signaling by GPCR—IL2—lung cancer	0.000143	0.000277	CbGpPWpGaD
Papaverine—PDE4B—GPCR downstream signaling—CXCL8—lung cancer	0.000143	0.000276	CbGpPWpGaD
Papaverine—PDE3B—Signaling Pathways—TERT—lung cancer	0.000143	0.000276	CbGpPWpGaD
Papaverine—PDE10A—Signaling Pathways—PIK3CB—lung cancer	0.000142	0.000275	CbGpPWpGaD
Papaverine—PDE10A—Signaling Pathways—MTOR—lung cancer	0.000142	0.000275	CbGpPWpGaD
Papaverine—PDE3A—Signaling by GPCR—PIK3CB—lung cancer	0.000142	0.000274	CbGpPWpGaD
Papaverine—PDE4B—Signaling Pathways—HES1—lung cancer	0.000141	0.000273	CbGpPWpGaD
Papaverine—PDE3A—Hemostasis—HRAS—lung cancer	0.00014	0.00027	CbGpPWpGaD
Papaverine—PDE3B—Signaling Pathways—FGFR1—lung cancer	0.000138	0.000268	CbGpPWpGaD
Papaverine—PDE4B—Signaling by GPCR—RAF1—lung cancer	0.000138	0.000267	CbGpPWpGaD
Papaverine—PDE10A—Signaling Pathways—CXCL8—lung cancer	0.000137	0.000264	CbGpPWpGaD
Papaverine—PDE4B—GPCR downstream signaling—IL2—lung cancer	0.000137	0.000264	CbGpPWpGaD
Papaverine—PDE3A—Signaling by GPCR—CXCL8—lung cancer	0.000136	0.000264	CbGpPWpGaD
Papaverine—PDE3B—Signaling Pathways—HIF1A—lung cancer	0.000136	0.000264	CbGpPWpGaD
Papaverine—PDE10A—Signaling by GPCR—HRAS—lung cancer	0.000136	0.000263	CbGpPWpGaD
Papaverine—PDE3A—Signaling Pathways—ERBB3—lung cancer	0.000136	0.000262	CbGpPWpGaD
Papaverine—PDE3B—Hemostasis—AKT1—lung cancer	0.000135	0.000261	CbGpPWpGaD
Papaverine—PDE4B—Signaling by GPCR—PIK3CB—lung cancer	0.000135	0.000261	CbGpPWpGaD
Papaverine—PDE10A—GPCR downstream signaling—AKT1—lung cancer	0.000132	0.000255	CbGpPWpGaD
Papaverine—PDE3B—Signaling Pathways—APOA1—lung cancer	0.000132	0.000254	CbGpPWpGaD
Papaverine—PDE10A—Signaling Pathways—CASP3—lung cancer	0.000131	0.000253	CbGpPWpGaD
Papaverine—PDE10A—Signaling Pathways—IL2—lung cancer	0.000131	0.000253	CbGpPWpGaD
Papaverine—PDE3B—Signaling Pathways—KDR—lung cancer	0.00013	0.000252	CbGpPWpGaD
Papaverine—PDE3A—Signaling by GPCR—IL2—lung cancer	0.00013	0.000252	CbGpPWpGaD
Papaverine—PDE10A—Signaling by GPCR—IL6—lung cancer	0.00013	0.000251	CbGpPWpGaD
Papaverine—PDE3A—Signaling Pathways—TERT—lung cancer	0.00013	0.000251	CbGpPWpGaD
Papaverine—PDE4B—Signaling by GPCR—CXCL8—lung cancer	0.00013	0.000251	CbGpPWpGaD
Papaverine—PDE4B—Signaling Pathways—ERBB3—lung cancer	0.000129	0.000249	CbGpPWpGaD
Papaverine—PDE10A—Signaling Pathways—CCND1—lung cancer	0.000127	0.000246	CbGpPWpGaD
Papaverine—PDE10A—Signaling Pathways—JUN—lung cancer	0.000127	0.000246	CbGpPWpGaD
Papaverine—PDE3A—Signaling Pathways—FGFR1—lung cancer	0.000126	0.000244	CbGpPWpGaD
Papaverine—PDE3A—Signaling Pathways—HIF1A—lung cancer	0.000124	0.00024	CbGpPWpGaD
Papaverine—PDE4B—Signaling by GPCR—IL2—lung cancer	0.000124	0.00024	CbGpPWpGaD
Papaverine—PDE10A—Signaling Pathways—MMP9—lung cancer	0.000124	0.000239	CbGpPWpGaD
Papaverine—PDE4B—Signaling Pathways—TERT—lung cancer	0.000124	0.000239	CbGpPWpGaD
Papaverine—PDE10A—Signaling Pathways—CDKN1A—lung cancer	0.000123	0.000238	CbGpPWpGaD
Papaverine—PDE3A—Hemostasis—AKT1—lung cancer	0.000123	0.000238	CbGpPWpGaD
Papaverine—PDE10A—Signaling Pathways—PTEN—lung cancer	0.000123	0.000238	CbGpPWpGaD
Papaverine—PDE3B—Signaling Pathways—APC—lung cancer	0.00012	0.000232	CbGpPWpGaD
Papaverine—PDE3B—Signaling Pathways—KIT—lung cancer	0.00012	0.000232	CbGpPWpGaD
Papaverine—PDE3B—Signaling Pathways—PIK3CG—lung cancer	0.00012	0.000232	CbGpPWpGaD
Papaverine—PDE3B—Signaling by GPCR—NRAS—lung cancer	0.00012	0.000232	CbGpPWpGaD
Papaverine—PDE4B—Signaling Pathways—FGFR1—lung cancer	0.00012	0.000232	CbGpPWpGaD
Papaverine—PDE10A—Signaling by GPCR—AKT1—lung cancer	0.00012	0.000232	CbGpPWpGaD
Papaverine—PDE3A—Signaling Pathways—APOA1—lung cancer	0.00012	0.000232	CbGpPWpGaD
Papaverine—PDE3A—Signaling Pathways—KDR—lung cancer	0.000119	0.00023	CbGpPWpGaD
Papaverine—PDE3B—Signaling Pathways—EGF—lung cancer	0.000119	0.00023	CbGpPWpGaD
Papaverine—PDE4B—Signaling Pathways—HIF1A—lung cancer	0.000118	0.000228	CbGpPWpGaD
Papaverine—PDE10A—Signaling Pathways—EP300—lung cancer	0.000117	0.000227	CbGpPWpGaD
Papaverine—PDE3B—Signaling by GPCR—MAPK3—lung cancer	0.000115	0.000222	CbGpPWpGaD
Papaverine—PDE3B—Signaling Pathways—POMC—lung cancer	0.000114	0.000221	CbGpPWpGaD
Papaverine—PDE4B—Signaling Pathways—APOA1—lung cancer	0.000114	0.00022	CbGpPWpGaD
Papaverine—PDE10A—Signaling Pathways—SRC—lung cancer	0.000114	0.00022	CbGpPWpGaD
Papaverine—PDE4B—Signaling Pathways—KDR—lung cancer	0.000113	0.000218	CbGpPWpGaD
Papaverine—PDE3B—Signaling Pathways—BRAF—lung cancer	0.000113	0.000218	CbGpPWpGaD
Papaverine—PDE3B—Signaling Pathways—IL6R—lung cancer	0.000112	0.000216	CbGpPWpGaD
Papaverine—PDE3B—Signaling Pathways—CREBBP—lung cancer	0.000111	0.000215	CbGpPWpGaD
Papaverine—PDE10A—Signaling Pathways—VEGFA—lung cancer	0.000111	0.000215	CbGpPWpGaD
Papaverine—PDE10A—Signaling Pathways—STAT3—lung cancer	0.00011	0.000213	CbGpPWpGaD
Papaverine—PDE10A—Signaling Pathways—NRAS—lung cancer	0.00011	0.000212	CbGpPWpGaD
Papaverine—PDE3B—Signaling by GPCR—EGFR—lung cancer	0.000109	0.000212	CbGpPWpGaD
Papaverine—PDE3A—Signaling Pathways—APC—lung cancer	0.000109	0.000212	CbGpPWpGaD
Papaverine—PDE3A—Signaling Pathways—PIK3CG—lung cancer	0.000109	0.000212	CbGpPWpGaD
Papaverine—PDE3A—Signaling Pathways—KIT—lung cancer	0.000109	0.000212	CbGpPWpGaD
Papaverine—PDE3A—Signaling by GPCR—NRAS—lung cancer	0.000109	0.000212	CbGpPWpGaD
Papaverine—PDE3A—Signaling Pathways—EGF—lung cancer	0.000108	0.000209	CbGpPWpGaD
Papaverine—PDE3B—Signaling Pathways—MAP2K1—lung cancer	0.000106	0.000206	CbGpPWpGaD
Papaverine—PDE3B—Signaling Pathways—PIK3CD—lung cancer	0.000106	0.000204	CbGpPWpGaD
Papaverine—PDE10A—Signaling Pathways—MAPK3—lung cancer	0.000105	0.000203	CbGpPWpGaD
Papaverine—PDE3A—Signaling by GPCR—MAPK3—lung cancer	0.000105	0.000203	CbGpPWpGaD
Papaverine—PDE3B—GPCR downstream signaling—PIK3CA—lung cancer	0.000105	0.000202	CbGpPWpGaD
Papaverine—PDE3A—Signaling Pathways—POMC—lung cancer	0.000104	0.000201	CbGpPWpGaD
Papaverine—PDE4B—Signaling Pathways—KIT—lung cancer	0.000104	0.000201	CbGpPWpGaD
Papaverine—PDE4B—Signaling Pathways—PIK3CG—lung cancer	0.000104	0.000201	CbGpPWpGaD
Papaverine—PDE4B—Signaling Pathways—APC—lung cancer	0.000104	0.000201	CbGpPWpGaD
Papaverine—PDE4B—Signaling by GPCR—NRAS—lung cancer	0.000104	0.000201	CbGpPWpGaD
Papaverine—PDE3B—Signaling by GPCR—KRAS—lung cancer	0.000103	0.0002	CbGpPWpGaD
Papaverine—PDE4B—Signaling Pathways—EGF—lung cancer	0.000103	0.000199	CbGpPWpGaD
Papaverine—PDE3A—Signaling Pathways—BRAF—lung cancer	0.000103	0.000199	CbGpPWpGaD
Papaverine—PDE10A—Signaling Pathways—MYC—lung cancer	0.000102	0.000197	CbGpPWpGaD
Papaverine—PDE3A—Signaling Pathways—IL6R—lung cancer	0.000102	0.000196	CbGpPWpGaD
Papaverine—PDE3A—Signaling Pathways—CREBBP—lung cancer	0.000101	0.000196	CbGpPWpGaD
Papaverine—PDE10A—Signaling Pathways—EGFR—lung cancer	0.0001	0.000193	CbGpPWpGaD
Papaverine—PDE3A—Signaling by GPCR—EGFR—lung cancer	9.97e-05	0.000193	CbGpPWpGaD
Papaverine—PDE4B—Signaling by GPCR—MAPK3—lung cancer	9.97e-05	0.000193	CbGpPWpGaD
Papaverine—PDE4B—Signaling Pathways—POMC—lung cancer	9.91e-05	0.000192	CbGpPWpGaD
Papaverine—PDE4B—Signaling Pathways—BRAF—lung cancer	9.79e-05	0.000189	CbGpPWpGaD
Papaverine—PDE3A—Signaling Pathways—MAP2K1—lung cancer	9.69e-05	0.000187	CbGpPWpGaD
Papaverine—PDE4B—Signaling Pathways—IL6R—lung cancer	9.67e-05	0.000187	CbGpPWpGaD
Papaverine—PDE4B—Signaling Pathways—CREBBP—lung cancer	9.65e-05	0.000187	CbGpPWpGaD
Papaverine—PDE3A—Signaling Pathways—PIK3CD—lung cancer	9.62e-05	0.000186	CbGpPWpGaD
Papaverine—PDE3A—GPCR downstream signaling—PIK3CA—lung cancer	9.53e-05	0.000184	CbGpPWpGaD
Papaverine—PDE3B—Signaling by GPCR—PIK3CA—lung cancer	9.5e-05	0.000184	CbGpPWpGaD
Papaverine—PDE4B—Signaling by GPCR—EGFR—lung cancer	9.49e-05	0.000183	CbGpPWpGaD
Papaverine—PDE3B—Signaling Pathways—MDM2—lung cancer	9.46e-05	0.000183	CbGpPWpGaD
Papaverine—PDE10A—Signaling Pathways—KRAS—lung cancer	9.44e-05	0.000182	CbGpPWpGaD
Papaverine—PDE3B—Signaling Pathways—RAF1—lung cancer	9.43e-05	0.000182	CbGpPWpGaD
Papaverine—PDE3A—Signaling by GPCR—KRAS—lung cancer	9.42e-05	0.000182	CbGpPWpGaD
Papaverine—PDE3B—Signaling Pathways—ERBB2—lung cancer	9.33e-05	0.00018	CbGpPWpGaD
Papaverine—PDE4B—Signaling Pathways—MAP2K1—lung cancer	9.21e-05	0.000178	CbGpPWpGaD
Papaverine—PDE3B—Signaling Pathways—MTOR—lung cancer	9.21e-05	0.000178	CbGpPWpGaD
Papaverine—PDE3B—Signaling Pathways—PIK3CB—lung cancer	9.21e-05	0.000178	CbGpPWpGaD
Papaverine—PDE4B—Signaling Pathways—PIK3CD—lung cancer	9.15e-05	0.000177	CbGpPWpGaD
Papaverine—PDE4B—GPCR downstream signaling—PIK3CA—lung cancer	9.07e-05	0.000175	CbGpPWpGaD
Papaverine—PDE4B—Signaling by GPCR—KRAS—lung cancer	8.96e-05	0.000173	CbGpPWpGaD
Papaverine—PDE3B—Signaling Pathways—CXCL8—lung cancer	8.85e-05	0.000171	CbGpPWpGaD
Papaverine—PDE3B—Signaling by GPCR—HRAS—lung cancer	8.79e-05	0.00017	CbGpPWpGaD
Papaverine—PDE10A—Signaling Pathways—PIK3CA—lung cancer	8.67e-05	0.000168	CbGpPWpGaD
Papaverine—PDE3A—Signaling by GPCR—PIK3CA—lung cancer	8.65e-05	0.000167	CbGpPWpGaD
Papaverine—PDE3A—Signaling Pathways—MDM2—lung cancer	8.62e-05	0.000167	CbGpPWpGaD
Papaverine—PDE3A—Signaling Pathways—RAF1—lung cancer	8.59e-05	0.000166	CbGpPWpGaD
Papaverine—PDE3B—GPCR downstream signaling—AKT1—lung cancer	8.55e-05	0.000165	CbGpPWpGaD
Papaverine—PDE3A—Signaling Pathways—ERBB2—lung cancer	8.5e-05	0.000164	CbGpPWpGaD
Papaverine—PDE3B—Signaling Pathways—CASP3—lung cancer	8.47e-05	0.000164	CbGpPWpGaD
Papaverine—PDE3B—Signaling Pathways—IL2—lung cancer	8.46e-05	0.000163	CbGpPWpGaD
Papaverine—PDE3B—Signaling by GPCR—IL6—lung cancer	8.41e-05	0.000163	CbGpPWpGaD
Papaverine—PDE10A—Signaling Pathways—TP53—lung cancer	8.39e-05	0.000162	CbGpPWpGaD
Papaverine—PDE3A—Signaling Pathways—PIK3CB—lung cancer	8.39e-05	0.000162	CbGpPWpGaD
Papaverine—PDE3A—Signaling Pathways—MTOR—lung cancer	8.39e-05	0.000162	CbGpPWpGaD
Papaverine—PDE3B—Signaling Pathways—CCND1—lung cancer	8.24e-05	0.000159	CbGpPWpGaD
Papaverine—PDE4B—Signaling by GPCR—PIK3CA—lung cancer	8.23e-05	0.000159	CbGpPWpGaD
Papaverine—PDE3B—Signaling Pathways—JUN—lung cancer	8.23e-05	0.000159	CbGpPWpGaD
Papaverine—PDE4B—Signaling Pathways—MDM2—lung cancer	8.2e-05	0.000158	CbGpPWpGaD
Papaverine—PDE4B—Signaling Pathways—RAF1—lung cancer	8.17e-05	0.000158	CbGpPWpGaD
Papaverine—PDE4B—Signaling Pathways—ERBB2—lung cancer	8.08e-05	0.000156	CbGpPWpGaD
Papaverine—PDE3A—Signaling Pathways—CXCL8—lung cancer	8.06e-05	0.000156	CbGpPWpGaD
Papaverine—PDE10A—Signaling Pathways—HRAS—lung cancer	8.03e-05	0.000155	CbGpPWpGaD
Papaverine—PDE3A—Signaling by GPCR—HRAS—lung cancer	8.01e-05	0.000155	CbGpPWpGaD
Papaverine—PDE3B—Signaling Pathways—MMP9—lung cancer	8e-05	0.000155	CbGpPWpGaD
Papaverine—PDE4B—Signaling Pathways—PIK3CB—lung cancer	7.98e-05	0.000154	CbGpPWpGaD
Papaverine—PDE4B—Signaling Pathways—MTOR—lung cancer	7.98e-05	0.000154	CbGpPWpGaD
Papaverine—PDE3B—Signaling Pathways—CDKN1A—lung cancer	7.98e-05	0.000154	CbGpPWpGaD
Papaverine—PDE3B—Signaling Pathways—PTEN—lung cancer	7.96e-05	0.000154	CbGpPWpGaD
Papaverine—PDE3A—GPCR downstream signaling—AKT1—lung cancer	7.79e-05	0.00015	CbGpPWpGaD
Papaverine—PDE3B—Signaling by GPCR—AKT1—lung cancer	7.76e-05	0.00015	CbGpPWpGaD
Papaverine—PDE3A—Signaling Pathways—CASP3—lung cancer	7.71e-05	0.000149	CbGpPWpGaD
Papaverine—PDE3A—Signaling Pathways—IL2—lung cancer	7.7e-05	0.000149	CbGpPWpGaD
Papaverine—PDE10A—Signaling Pathways—IL6—lung cancer	7.68e-05	0.000148	CbGpPWpGaD
Papaverine—PDE4B—Signaling Pathways—CXCL8—lung cancer	7.67e-05	0.000148	CbGpPWpGaD
Papaverine—PDE3A—Signaling by GPCR—IL6—lung cancer	7.66e-05	0.000148	CbGpPWpGaD
Papaverine—PDE4B—Signaling by GPCR—HRAS—lung cancer	7.62e-05	0.000147	CbGpPWpGaD
Papaverine—PDE3B—Signaling Pathways—EP300—lung cancer	7.59e-05	0.000147	CbGpPWpGaD
Papaverine—PDE3A—Signaling Pathways—CCND1—lung cancer	7.51e-05	0.000145	CbGpPWpGaD
Papaverine—PDE3A—Signaling Pathways—JUN—lung cancer	7.49e-05	0.000145	CbGpPWpGaD
Papaverine—PDE4B—GPCR downstream signaling—AKT1—lung cancer	7.41e-05	0.000143	CbGpPWpGaD
Papaverine—PDE3B—Signaling Pathways—SRC—lung cancer	7.38e-05	0.000143	CbGpPWpGaD
Papaverine—PDE4B—Signaling Pathways—CASP3—lung cancer	7.34e-05	0.000142	CbGpPWpGaD
Papaverine—PDE4B—Signaling Pathways—IL2—lung cancer	7.33e-05	0.000142	CbGpPWpGaD
Papaverine—PDE3A—Signaling Pathways—MMP9—lung cancer	7.29e-05	0.000141	CbGpPWpGaD
Papaverine—PDE4B—Signaling by GPCR—IL6—lung cancer	7.29e-05	0.000141	CbGpPWpGaD
Papaverine—PDE3A—Signaling Pathways—CDKN1A—lung cancer	7.26e-05	0.00014	CbGpPWpGaD
Papaverine—PDE3A—Signaling Pathways—PTEN—lung cancer	7.25e-05	0.00014	CbGpPWpGaD
Papaverine—PDE3B—Signaling Pathways—VEGFA—lung cancer	7.19e-05	0.000139	CbGpPWpGaD
Papaverine—PDE4B—Signaling Pathways—CCND1—lung cancer	7.14e-05	0.000138	CbGpPWpGaD
Papaverine—PDE4B—Signaling Pathways—JUN—lung cancer	7.13e-05	0.000138	CbGpPWpGaD
Papaverine—PDE3B—Signaling Pathways—STAT3—lung cancer	7.12e-05	0.000138	CbGpPWpGaD
Papaverine—PDE3B—Signaling Pathways—NRAS—lung cancer	7.1e-05	0.000137	CbGpPWpGaD
Papaverine—PDE10A—Signaling Pathways—AKT1—lung cancer	7.09e-05	0.000137	CbGpPWpGaD
Papaverine—PDE3A—Signaling by GPCR—AKT1—lung cancer	7.07e-05	0.000137	CbGpPWpGaD
Papaverine—PDE4B—Signaling Pathways—MMP9—lung cancer	6.93e-05	0.000134	CbGpPWpGaD
Papaverine—PDE3A—Signaling Pathways—EP300—lung cancer	6.91e-05	0.000134	CbGpPWpGaD
Papaverine—PDE4B—Signaling Pathways—CDKN1A—lung cancer	6.91e-05	0.000134	CbGpPWpGaD
Papaverine—PDE4B—Signaling Pathways—PTEN—lung cancer	6.89e-05	0.000133	CbGpPWpGaD
Papaverine—PDE3B—Signaling Pathways—MAPK3—lung cancer	6.8e-05	0.000131	CbGpPWpGaD
Papaverine—PDE4B—Signaling by GPCR—AKT1—lung cancer	6.72e-05	0.00013	CbGpPWpGaD
Papaverine—PDE3A—Signaling Pathways—SRC—lung cancer	6.72e-05	0.00013	CbGpPWpGaD
Papaverine—PDE3B—Signaling Pathways—MYC—lung cancer	6.61e-05	0.000128	CbGpPWpGaD
Papaverine—PDE4B—Signaling Pathways—EP300—lung cancer	6.57e-05	0.000127	CbGpPWpGaD
Papaverine—PDE3A—Signaling Pathways—VEGFA—lung cancer	6.55e-05	0.000127	CbGpPWpGaD
Papaverine—PDE3A—Signaling Pathways—STAT3—lung cancer	6.48e-05	0.000125	CbGpPWpGaD
Papaverine—PDE3B—Signaling Pathways—EGFR—lung cancer	6.47e-05	0.000125	CbGpPWpGaD
Papaverine—PDE3A—Signaling Pathways—NRAS—lung cancer	6.47e-05	0.000125	CbGpPWpGaD
Papaverine—PDE4B—Signaling Pathways—SRC—lung cancer	6.39e-05	0.000124	CbGpPWpGaD
Papaverine—PDE4B—Signaling Pathways—VEGFA—lung cancer	6.23e-05	0.00012	CbGpPWpGaD
Papaverine—PDE3A—Signaling Pathways—MAPK3—lung cancer	6.19e-05	0.00012	CbGpPWpGaD
Papaverine—PDE4B—Signaling Pathways—STAT3—lung cancer	6.16e-05	0.000119	CbGpPWpGaD
Papaverine—PDE4B—Signaling Pathways—NRAS—lung cancer	6.15e-05	0.000119	CbGpPWpGaD
Papaverine—PDE3B—Signaling Pathways—KRAS—lung cancer	6.11e-05	0.000118	CbGpPWpGaD
Papaverine—PDE3A—Signaling Pathways—MYC—lung cancer	6.02e-05	0.000116	CbGpPWpGaD
Papaverine—PDE3A—Signaling Pathways—EGFR—lung cancer	5.89e-05	0.000114	CbGpPWpGaD
Papaverine—PDE4B—Signaling Pathways—MAPK3—lung cancer	5.89e-05	0.000114	CbGpPWpGaD
Papaverine—PDE4B—Signaling Pathways—MYC—lung cancer	5.73e-05	0.000111	CbGpPWpGaD
Papaverine—PDE3B—Signaling Pathways—PIK3CA—lung cancer	5.61e-05	0.000108	CbGpPWpGaD
Papaverine—PDE4B—Signaling Pathways—EGFR—lung cancer	5.6e-05	0.000108	CbGpPWpGaD
Papaverine—PDE3A—Signaling Pathways—KRAS—lung cancer	5.56e-05	0.000108	CbGpPWpGaD
Papaverine—PDE3B—Signaling Pathways—TP53—lung cancer	5.43e-05	0.000105	CbGpPWpGaD
Papaverine—PDE4B—Signaling Pathways—KRAS—lung cancer	5.29e-05	0.000102	CbGpPWpGaD
Papaverine—PDE3B—Signaling Pathways—HRAS—lung cancer	5.19e-05	0.0001	CbGpPWpGaD
Papaverine—PDE3A—Signaling Pathways—PIK3CA—lung cancer	5.11e-05	9.88e-05	CbGpPWpGaD
Papaverine—PDE3B—Signaling Pathways—IL6—lung cancer	4.97e-05	9.61e-05	CbGpPWpGaD
Papaverine—PDE3A—Signaling Pathways—TP53—lung cancer	4.95e-05	9.56e-05	CbGpPWpGaD
Papaverine—PDE4B—Signaling Pathways—PIK3CA—lung cancer	4.86e-05	9.4e-05	CbGpPWpGaD
Papaverine—PDE3A—Signaling Pathways—HRAS—lung cancer	4.73e-05	9.14e-05	CbGpPWpGaD
Papaverine—PDE4B—Signaling Pathways—TP53—lung cancer	4.7e-05	9.09e-05	CbGpPWpGaD
Papaverine—PDE3B—Signaling Pathways—AKT1—lung cancer	4.59e-05	8.86e-05	CbGpPWpGaD
Papaverine—PDE3A—Signaling Pathways—IL6—lung cancer	4.53e-05	8.75e-05	CbGpPWpGaD
Papaverine—PDE4B—Signaling Pathways—HRAS—lung cancer	4.5e-05	8.69e-05	CbGpPWpGaD
Papaverine—PDE4B—Signaling Pathways—IL6—lung cancer	4.31e-05	8.32e-05	CbGpPWpGaD
Papaverine—PDE3A—Signaling Pathways—AKT1—lung cancer	4.18e-05	8.07e-05	CbGpPWpGaD
Papaverine—PDE4B—Signaling Pathways—AKT1—lung cancer	3.97e-05	7.68e-05	CbGpPWpGaD
